Michael Healy is an innovative business development executive in the pharmaceutical and biotech industries, currently serving as Director of National Accounts at Gilead Sciences. With experience that spans over two decades, they have successfully negotiated and implemented strategic initiatives that resulted in multi-million dollar revenue impacts, including securing preferred status for key products like Harvoni and Sovaldi. Michael has a Bachelor of Science in Business Administration and Economics from Northern Michigan University and has been recognized for their motivational leadership and ability to build strategic partnerships. Prior to their current role, they held various positions at Gilead, Eli Lilly, Johnson & Johnson, Elan, and Ortho-McNeil Pharmaceutical, driving sales growth and market share across multiple therapeutic areas.
This person is not in the org chart
This person is not in any teams
This person is not in any offices